Day 1
October 15, 2024

7:00 am
Registration Opens and Continental Breakfast Served
7:30 am
Breakfast with the Chicago Chapter of ACI’s Hatch Waxman Advisory Board
8:30 am
Co-Chairs Opening Remarks
8:45 am
State of the Union on Small Molecule Patents
10:00 am
Morning Coffee and Networking Break
10:15 am
Assessing Patent Portfolios Post In Re Cellect: Insights on Obviousness Type Double Patenting, PTA and Terminal Disclaimers
11:15 am
Special Focus on §103
Examining the Use of Clinical Trials as Prior Art: How to Thread the Needle on Protecting IP and Mandated Disclosures
12:00 pm
Networking Lunch
1:00 pm
Musings from Chief IP Counsel and General Counsel: A Roundtable Discussion on In House Strategy for the Current Pharmaceutical IP Landscape
2:00 pm
112 Think Tank: Brand Name and Generic Perspectives on Patent Claim Strategies and Enablement
2:45 pm
European Perspective on Claims Drafting and Plausibility and its Impacts on Hatch-Waxman Strategies in the US
3:15 pm
Afternoon Networking and Refreshment Break
3:30 pm
Views from the Bench
District Court Judges on the Present Paragraph IV Litigation Landscape: Analysis of Filing Trends, Settlements and Timings
4:30 pm
Patent Rights and Supply Chain Dynamics: Understanding How Developments in India May Affect Hatch-Waxman
5:00 pm
Cocktail Reception

Day 2
October 16, 2024

7:15 am
Registration Opens and Breakfast Served
7:45 am
Early Riser Discussion on DEI Leadership
8:45 am
Co-Chairs Opening Remarks

Spotlight on Antitrust and FTC Enforcement

9:00 am
Part I
Orange Book Patent War Room: Devising a Strategy to Defend Your Patents from Government Delisting Attempts
9:45 am
Part II
Round-up on Reverse Payment Settlements: Do’s, Don’t and Other Key Takeaways from Antitrust Litigation and Third-Party Payor Lawsuits
10:30 am
Morning Coffee Break
10:45 am
Fireside Chat on the Future of the FDA: Regulatory Initiatives, and Agency Developments for Hatch Waxman Practitioners to Watch
11:45 am
In Conversation with the PTAB: Preparing for Proposed Changes to Practices, Policies and Procedures
12:30 pm
Lunch Break
1:30 pm
Skinny Labeling and Induced Infringement Revisited: Analyzing the Latest in Section viii Carveout Cases
2:15 pm
Risky Business: At-Risk Launch Scenarios from Both the Brand and Generic Point of View
3:00 pm
Afternoon Networking and Refreshment Break
3:15 pm
Anticipating the Impact of AI on Drug Discovery and Future Hatch-Waxman Litigation
4:00 pm
Ethics for the Hatch Waxman Practitioner: A Scenario Based Discussion on Conduct, Communication and the Conundrums that Can Arise
5:00 pm
Conference Concludes